This signposted external event is not commissioned, organized or facilitated by C&P Training Hub. The availability of these offers are not checked on a daily basis and bookings are done directly with the supplier. You will not be able to see these on your Training Hub Account. Please contact the supplier directly if you have any questions, their contact details should be on your confirmation e-mails.

Morph study days are sponsored by pharmaceutical companies, who provide funding that allows us to offer all events completely free of charge. Sponsors have no involvement in agenda development, speaker selection, or clinical content – this is managed entirely by MORPh’s clinical team.

The “Focus on Frailty and High Quality SMRs for Pharmacists in Primary Care” Webinar is free to access both live and on-demand for attendees. To watch on-demand without attending the webinar you can join the Associate Programmme.

This event will start at 18:30pm with the Welcome and Introductions. The webinar will begin shortly after. Our expert speakers will be discussing the following topics:

Learning Objectives

By the end of today’s session, delegates will be able to:

  • Define frailty and differentiate it from multimorbidity, ageing, and acute deterioration
  • Apply principles of medicines optimisation in frailty, including recognising high‑risk medications and using tools such as STOPP/START and anticholinergic burden scales
  • Implement safe deprescribing strategies, balancing benefit vs risk to reduce treatment burden and prevent harm
  • Conduct high‑quality, person‑centred SMRs, incorporating shared decision‑making, functional status, cognition, and the patient’s priorities
  • Overview: Understanding Frailty
  • What is frailty? Clinical vs biological frailty
  • Mild, moderate, severe frailty and expected trajectories
  • Frailty syndromes (falls, delirium, incontinence, immobility)
  • Implications for medicines handling (PK/PD changes in older adults)
  • Learning activity: Participants classify a short patient scenario on the Rockwood scale
  • Medicines Optimisation in Frailty
  • High risk medications in frailty (opiates, sedatives, anticholinergics)
  • STOPP/START criteria
  • Anticholinergic burden tools
  • Deprescribing principles and tapering strategies
  • Prioritising symptom control vs disease control
  • Interactive task: Identify high risk drugs in a sample frail patient’s regimen
  • SMRs in Frailty – Doing Them Well
  • NHSE SMR guidance
  • Elements of a high quality frailty SMR
  • Holistic assessment (cognition, functional ability, social context)
  • Individualised targets (BP, HbA1c, lipids) in frail populations
  • Documenting high quality SMRs
  • Takeaway: Template for a high quality frailty focused SMR note